DE
Dianne Elizabeth Buchanan
About Dianne Elizabeth Buchanan
Data last updated:
Dianne Elizabeth Buchanan has experience in corporate governance. Holds Additional Director role. Currently with 1 company, including Odgers India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Odgers India Private Limited at ₹30.31 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Odgers India Private Limited U74140HR2011FTC044175 | Additional Director | 21 Nov 2025 | 2011 | ₹30.31 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dianne Elizabeth Buchanan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dianne Elizabeth Buchanan
Dianne Elizabeth Buchanan has experience in corporate governance. Holds Additional Director role. Currently with 1 company, including Odgers India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Odgers India Private Limited at ₹30.31 Cr (FY 2025).
Dianne Elizabeth Buchanan is associated with 1 company as Additional Director, including Odgers India Private Limited (₹30.31 Cr).
Dianne Elizabeth Buchanan has expertise in General Business.
Dianne Elizabeth Buchanan has extensive experience in corporate governance.
By reported revenue, the largest current company of Dianne Elizabeth Buchanan is Odgers India Private Limited, with revenue of ₹30.31 Cr (FY 2025).
Dianne Elizabeth Buchanan currently holds positions at 1 company: Odgers India Private Limited (₹30.31 Cr).